Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership
The takeover will give Amneal control of four facilities to manufacture biosimilars for a planned wave of launches in the coming years.
Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership Read More »
